Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Product categories
Product categories
Medical Treatment
Products 21 to 30 of 44
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
INXN-3004: AML
by
Intrexon
Biotech components:
Virus
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 09:59 (4 years ago)
Date last modified:
2020/02/10 09:59 (4 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Malonic Acid
by
Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
13,100,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Mandelic Acid
by
MONAD Nanotech
+
Birla College
Biotech components:
Plant
Business models:
B2B
Country of production:
India
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
University
+
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Personal Care (Topical)
+
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Mast-MO (antibiotic wasp venom)
by
University of Pennsylvania’s Perelman School of Medicine
Biotech components:
Animal
+
Bacteria
+
Molecule
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:40 (3 years ago)
Date last modified:
2020/12/18 14:40 (3 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
MG53 (natural human protein) (preventing lethal lung damage from the flu)
by
Ohio State University
Biotech components:
Molecule
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (3 years ago)
Date last modified:
2020/12/18 14:39 (3 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medicine
+
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Myristoyl Glutamate (Surfactant)
by
Modular Genetics, Inc.
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
1,121,998 USD
Funding types:
Private Funding
+
University
+
Government
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
NanoHeal
by
RISE PFI AS
Biotech components:
Molecule
Business models:
B2B
Country of production:
Norway
Country of distribution:
Norway
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:51 (6 years ago)
Known funding amount:
N/A
Funding types:
Government
+
University
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
ON-OFF Switch for Biocontainment
by
Synvivia
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Commercial
+
Government
+
TBD
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
295,172 USD
Funding types:
Government
+
Venture Capital
Industry:
Food & Agriculture
+
Health
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Soil Amendment
+
Medical Treatment
+
Other (Industrial)
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
PRGN-3005: Cancer
by
Intrexon
Biotech components:
Gene Editing
+
Molecule
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:31 (5 years ago)
Date last modified:
2019/09/12 14:31 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
PRGN-3006: AML and MDS
by
Intrexon
Biotech components:
Gene Editing
+
Molecule
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:32 (5 years ago)
Date last modified:
2019/09/12 14:32 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
1
2
3
4
5
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
